Clinical Trials Browser

Phase 2 × INDUSTRY × talquetamab × Clear all

NCT04634552 2026-03-17

MonumenTAL-1

Phase 2 Recruiting

510 enrolled 1 FDA

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT06577025 2026-03-13

aMMbition

Phase 2 Active not recruiting

Multiple Myeloma

NCT03601078 2026-03-04

KarMMa-2

Phase 2 Completed

Multiple Myeloma, Recurrence

NCT06500884 2026-02-13

Talisman

Phase 2 Recruiting

Multiple Myeloma